Abstract:Abstract Alternative RNA splicing is an essential mechanism linking genetic variation to human diseases. While the signals from genome-wide association studies (GWAS) have been linked to expression quantitative trait loci (eQTL) in previous studies, further work is needed to better elucidate the relationship to other genetic regulatory mechanisms, such as splicing QTLs (sQTL). Here, we performed a genome-wide sQTL analysis to identify variants that might affect RNA splicing in 1,010 non–small cell lung cancer (NSCLC) samples from The Cancer Genome Atlas. The identified sQTLs were largely independent of eQTLs and were predominantly enriched in exonic regions, genetic regulatory elements, RNA-binding protein (RBP) binding sites, and known NSCLC risk loci. In addition, target genes affected by sQTLs (sGenes) were involved in multiple processes in cancer, including cell growth, apoptosis, metabolism, immune infiltration, and drug responses, and sGenes were frequently altered genetically in NSCLC. Systematic screening of sQTLs associated with NSCLC risk using GWAS data from 15,474 cases and 12,375 controls identified an sQTL variant rs156697-G allele that was significantly associated with an increased risk of NSCLC. The association between the rs156697-G variant and NSCLC risk was further validated in two additional large population cohorts. The risk variant promoted inclusion of GSTO2 alternative exon 5 and led to higher expression of the GSTO2 full-length isoform (GSTO2-V1) and lower expression of the truncated GSTO2 isoform (GSTO2-V2), which was induced by RBP quaking (QKI). Mechanistically, compared with GSTO2-V1, GSTO2-V2 inhibited NSCLC cells proliferation by increasing S-glutathionylation of AKT1 and thereby functionally blocking AKT1 phosphorylation and activation. Overall, this study provides a comprehensive view of splicing variants linked to NSCLC risk and provides a set of genetic targets with therapeutic potential. Significance: Analysis of sQTL reveals the role of genetically driven mRNA splicing alterations in NSCLC risk and elucidates that rs156697 variant impacts risk by altering GSTO2 splicing.

Prioritizing Single-Nucleotide Variations That Potentially Regulate Alternative Splicing.

Alternative splicing at GYNNGY 5' splice sites: more noise, less regulation.

Regsnps-Splicing: a Tool for Prioritizing Synonymous Single-Nucleotide Substitution

ExonImpact: Prioritizing Pathogenic Alternative Splicing Events.

RNA splicing is a primary link between genetic variation and disease

Genomic features defining exonic variants that modulate splicing

Identification of synonymous pathogenic variants in monogenic disorders by integrating exome with transcriptome sequencing

Regsnps: a Strategy for Prioritizing Regulatory Single Nucleotide Substitutions.

Synonymous Variant at the Terminal Nucleotide in Exon 3 of F7 Causes Abnormal Splicing: A Case Report

The impact of genetically controlled splicing on exon inclusion and protein structure

Aberrant RNA Splicing As the Molecular Basis of Some Pathogenic Variants.

Alternative Splicing As a Biomarker and Potential Target for Drug Discovery

Impact of the RNA allosteric effect triggered by single nucleotide polymorphisms on the splicing process

Systematically developing a registry of splice-site creating variants utilizing massive publicly available transcriptome sequence data

A Deep Dive into Statistical Modeling of RNA Splicing QTLs Reveals New Variants that Explain Neurodegenerative Disease

Alternative splicing: Human disease and quantitative analysis from high-throughput sequencing

Deep indel mutagenesis reveals the regulatory and modulatory architecture of alternative exon splicing

Supplementary Data from Genome-Wide Splicing Quantitative Expression Locus Analysis Identifies Causal Risk Variants for Non–Small Cell Lung Cancer

Genetic regulation of nascent RNA maturation revealed by direct RNA nanopore sequencing

Mechanisms of Alternative Splicing Regulation: Insights from Molecular and Genomics Approaches

Integrating Whole Genome and Transcriptome Sequencing to Characterize the Genetic Architecture of Isoform Variation and its Implications for Health and Disease